Article ; Online: Nanoencapsulation of MDM2 Inhibitor RG7388 and Class-I HDAC Inhibitor Entinostat Enhances their Therapeutic Potential Through Synergistic Antitumor Effects and Reduction of Systemic Toxicity.
2024 Volume 21, Issue 3, Page(s) 1246–1255
Abstract: Inhibitors of the p53-MDM2 interaction such as RG7388 have been developed to exploit latent tumor suppressive properties in p53 in 50% of tumors in which p53 is wild-type. However, these agents for the most part activate cell cycle arrest rather than ... ...
Abstract | Inhibitors of the p53-MDM2 interaction such as RG7388 have been developed to exploit latent tumor suppressive properties in p53 in 50% of tumors in which p53 is wild-type. However, these agents for the most part activate cell cycle arrest rather than death, and high doses in patients elicit on-target dose-limiting neutropenia. Recent work from our group indicates that combination of p53-MDM2 inhibitors with the class-I HDAC inhibitor Entinostat (which itself has dose-limiting toxicity issues) has the potential to significantly augment cell death in p53 wild-type colorectal cancer cells. We investigated whether coencapsulation of RG7388 and Entinostat within polymeric nanoparticles (NPs) could overcome efficacy and toxicity limitations of this drug combination. Combinations of RG7388 and Entinostat across a range of different molar ratios resulted in synergistic increases in cell death when delivered in both free drug and nanoencapsulated formats in all colorectal cell lines tested. Importantly, we also explored the |
---|---|
MeSH term(s) | Humans ; Animals ; Mice ; Histone Deacetylase Inhibitors/pharmacology ; Histone Deacetylase Inhibitors/therapeutic use ; Tumor Suppressor Protein p53/metabolism ; Apoptosis ; Cell Line, Tumor ; Antineoplastic Agents/pharmacology ; Antineoplastic Agents/therapeutic use ; Drug Combinations ; Proto-Oncogene Proteins c-mdm2 ; Benzamides ; Pyridines ; Pyrrolidines ; para-Aminobenzoates |
Chemical Substances | Histone Deacetylase Inhibitors ; entinostat (1ZNY4FKK9H) ; RG7388 ; Tumor Suppressor Protein p53 ; Antineoplastic Agents ; Drug Combinations ; Proto-Oncogene Proteins c-mdm2 (EC 2.3.2.27) ; MDM2 protein, human (EC 2.3.2.27) ; Benzamides ; Pyridines ; Pyrrolidines ; para-Aminobenzoates |
Language | English |
Publishing date | 2024-02-09 |
Publishing country | United States |
Document type | Journal Article |
ZDB-ID | 2138405-8 |
ISSN | 1543-8392 ; 1543-8384 |
ISSN (online) | 1543-8392 |
ISSN | 1543-8384 |
DOI | 10.1021/acs.molpharmaceut.3c00926 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 6250: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.